{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:21:43Z","timestamp":1786123303942,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1213\/01.ane.0000239223.74552.0a","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T02:57:32Z","timestamp":1161140252000},"page":"1155-1162","source":"Crossref","is-referenced-by-count":52,"title":["The Additive Interactions Between Ondansetron and Droperidol for Preventing Postoperative Nausea and Vomiting"],"prefix":"10.1213","volume":"103","author":[{"given":"Matthew T. V.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai C.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Gin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po Tong","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pong Mo","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H. Y.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian C.","family":"Apfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong J.","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210902","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1213\/01.ANE.0000068580.00245.95","article-title":"Consensus guidelines for managing postoperative nausea and vomiting.","volume":"97","author":"Gan","year":"2003","journal-title":"Anesth Analg"},{"key":"R2-16-20210902","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000542-199712000-00004","article-title":"Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials.","volume":"87","author":"Tramer","year":"1997","journal-title":"Anesthesiology"},{"key":"R3-16-20210902","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1034\/j.1399-6576.2000.441011.x","article-title":"Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials.","volume":"44","author":"Eberhart","year":"2000","journal-title":"Acta Anaesthesiol Scand"},{"key":"R4-16-20210902","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa032196","article-title":"A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.","volume":"350","author":"Apfel","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-16-20210902","first-page":"353","article-title":"An analysis of the time-relation of electrocardiograms.","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"R6-16-20210902","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1213\/00000539-199607000-00021","article-title":"Combination of ondansetron and droperidol in the prophylaxis of postoperative nausea and vomiting.","volume":"83","author":"Pueyo","year":"1996","journal-title":"Anesth Analg"},{"key":"R7-16-20210902","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00003643-199707000-00004","article-title":"Ondansetron, droperidol and their combination for the prevention of post-operative vomiting in children.","volume":"14","author":"Klockgether-Radke","year":"1997","journal-title":"Eur J Anaesthesiol"},{"key":"R8-16-20210902","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/bja\/83.5.813","article-title":"Ondansetron and droperidol in the prevention of postoperative nausea and vomiting.","volume":"83","author":"Bugedo","year":"1999","journal-title":"Br J Anaesth"},{"key":"R9-16-20210902","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF03018944","article-title":"Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy.","volume":"47","author":"Wu","year":"2000","journal-title":"Can J Anaesth"},{"key":"R10-16-20210902","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1034\/j.1399-6576.2001.045006756.x","article-title":"Combination of droperidol and ondansetron reduces PONV after pediatric strabismus surgery more than single drug therapy.","volume":"45","author":"Shende","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-16-20210902","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R12-16-20210902","doi-asserted-by":"crossref","DOI":"10.4135\/9781412984515","article-title":"Interaction effects in logistic regression.","author":"Jaccard","year":"2001"},{"key":"R13-16-20210902","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0197-2456(03)00107-7","article-title":"An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2X2X2X2X2X2 factorial design (IMPACT).","volume":"24","author":"Apfel","year":"2003","journal-title":"Control Clin Trials"},{"key":"R14-16-20210902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.10.014","article-title":"Towards a mechanism-based analysis of pharmacodynamic drug\u2013drug interactions in vivo.","volume":"106","author":"Jonker","year":"2005","journal-title":"Pharmacol Ther"},{"key":"R15-16-20210902","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000542-199712000-00004","article-title":"Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a qualitative systematic review of randomized placebo-controlled trials.","volume":"87","author":"Tram\u00e8r","year":"1997","journal-title":"Anesthesiology"},{"key":"R16-16-20210902","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1034\/j.1399-6576.2000.441011.x","article-title":"Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials.","volume":"44","author":"Eberhart","year":"2000","journal-title":"Acta Anaesthesiol Scand"},{"key":"R17-16-20210902","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF03018234","article-title":"The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials.","volume":"51","author":"Habib","year":"2004","journal-title":"Can J Anaesth"},{"key":"R18-16-20210902","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/00000539-199802000-00010","article-title":"The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting.","volume":"86","author":"Tang","year":"1998","journal-title":"Anesth Analg"},{"key":"R19-16-20210902","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1213\/00000539-200210000-00001","article-title":"Droperidol: a cost-effective antiemetic for over thirty years [Editorial].","volume":"95","author":"White","year":"2002","journal-title":"Anesth Analg"},{"key":"R20-16-20210902","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1213\/01.ANE.0000077705.55641.6B","article-title":"Safety of patients reason for FDA black box warning on droperidol.","volume":"98","author":"Shafer","year":"2004","journal-title":"Anesth Analg"},{"key":"R21-16-20210902","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00000542-200506000-00007","article-title":"Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebocontrolled study.","volume":"102","author":"White","year":"2005","journal-title":"Anesthesiology"},{"key":"R22-16-20210902","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron.","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/01.ane.0000239223.74552.0a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:11:57Z","timestamp":1786111917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200611000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1213\/01.ane.0000239223.74552.0a","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}